查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942633

C反应蛋白检测全球市场报告（2026年）

C-Reactive Protein Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，C反应蛋白检测市场显着扩张，预计将从2025年的35.2亿美元成长到2026年的37亿美元，复合年增长率为5.1%。过去几年的增长可归因于多种因素，例如炎症性疾病患病率的上升、CRP检测在临床诊断中应用日益广泛、医院检查室基础设施的扩建、人们对疾病早期检测意识提升以及标准化检测套组的广泛使用。

预计未来几年C反应蛋白（CRP）检测市场将稳定成长，到2030年市场规模将达到44.8亿美元，复合年增长率（CAGR）为4.9%。预测期内的成长要素包括：照护现场发炎检测需求不断增长、自动化诊断平台整合程度不断提高、预防性健康筛检范围扩大、高通量检测系统应用日益广泛以及对个人化医疗诊断的日益重视。预测期内的主要趋势包括：高灵敏度CRP检测法的应用日益普及、自动化免疫检测系统使用率不断提高、对快速发炎诊断的需求不断增长、CRP检测在心血管风险评估中的应用范围扩大以及对检查室工作流程自动化的日益重视。

心血管疾病（CVD）发生率的不断上升预计将推动C反应蛋白检测市场的成长。心血管疾病包括血管疾病、结构性问题和血栓等心臟疾病。虽然心血管疾病的确切病因尚未完全明确，但多种因素会增加罹病风险。其中一个关键因素是行为风险，例如不良饮食、缺乏运动、吸烟和饮酒。这些因素会促进动脉内脂肪沉积（动脉粥状硬化），并增加血栓形成的风险。这些行为风险也会导致高血压、高血糖、高血脂症、体重增加和肥胖。随着心血管疾病发生率的上升，人们对C反应蛋白检测的需求（类似胆固醇检测）也不断增长，以用于心血管疾病的诊断和预测。例如，根据健康指标与评估研究所 (IHME) 于 2023 年 12 月发布的报告，2022 年全球心血管疾病死亡人数将达到 1,980 万，缺血性心臟疾病死亡率将达到每 10 万人 108.8 人。收缩期高血压是导致心血管疾病相关失能调整后存活年(DALY) 的主要因素，而饮食风险和空气污染正成为加剧此全球性挑战的重要行为和环境因素。

C反应蛋白 (CRP) 检测市场的主要企业正致力于技术创新，例如高灵敏度自动化免疫检测，该方法能够更准确、快速地检测低浓度CRP，从而支持早期心血管风险评估和即时发炎监测。高灵敏度自动化免疫检测分析法采用改良的免疫浊度或散射比浊法技术，能够检测到远低于标准检测法的CRP浓度，从而实现早期疗育和更佳的预后。 2024年1月，总部位于德国的体外诊断公司西门子医疗宣布推出适用于其Atellica CH分析仪的Atellica CH高灵敏度C反应蛋白2 (hCRP2) 检测系统。该系统使用两个即用型试剂盒，透过测量CRP颗粒凝集引起的光散射来检测CRP。它能够快速提供血清或血浆检体的定量结果，从而支持及时的临床决策。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球C反应蛋白检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 扩大高灵敏度CRP检测法的应用
    • 扩大自动化免疫检测系统的应用
    • 对快速发炎诊断的需求日益增长
    • 扩大CRP检测在心血管风险评估的应用
    • 日益关注检查室工作流程自动化

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 诊所
  • 专业医疗中心
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球C反应蛋白检测市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球C反应蛋白检测市场规模、对比及成长率分析
  • 全球C反应蛋白检测市场表现：规模与成长，2020-2025年
  • 全球C反应蛋白检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按检测类型
  • 酵素免疫分析法(ELISA)、化学冷光免疫检测分析 (CLIA)、免疫比浊检测法
  • 透过使用
  • 糖尿病、类风湿性关节炎、心血管疾病、发炎性肠道疾病、癌症及其他用途
  • 按最终用途
  • 诊所、医院和诊断检查室
  • 按类型细分：酵素免疫分析法试验 (ELISA)
  • 直接ELISA、间接ELISA、夹心ELISA
  • 按类型细分：化学冷光免疫检测(CLIA)
  • 基于发光仪的化学发光免疫分析法（CLIA），自动化化学发光免疫分析系统
  • 依类型细分：检测法
  • 基于浊度法的检测法浊法，乳胶凝集检测法

第十章 区域与国家分析

  • 全球C反应蛋白检测市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球C反应蛋白检测市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • C反应蛋白检测市场：竞争格局及市场占有率（2024年）
  • C反应蛋白检测市场：公司估值矩阵
  • C反应蛋白检测市场：公司概况
    • Thermo Fisher Scientific Inc.
    • F Hoffmann-La Roche AG
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Siemens AG

第37章：其他领先和创新企业

  • Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin SpA, Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年C反应蛋白检测市场：提供新机会的国家
  • C反应蛋白检测市场展望（2030）：新兴细分市场机会
  • C反应蛋白检测市场2030年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCRPT01_G26Q1

C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.

The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.

Tariffs are influencing the c-reactive protein testing market by increasing costs of imported reagents, assay kits, analyzers, and diagnostic instrumentation used across elisa, clia, and immunoturbidimetric platforms. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported testing systems, while Asia-Pacific faces cost pressures on reagent supply chains. These tariffs are raising operational costs and impacting test pricing. At the same time, they are encouraging local reagent manufacturing, regional analyzer assembly, and domestic diagnostic technology development.

The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with a c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The c-reactive protein testing market size has grown strongly in recent years. It will grow from $3.52 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing prevalence of inflammatory diseases, rising use of crp testing in clinical diagnostics, expansion of hospital laboratory infrastructure, growing awareness of early disease detection, availability of standardized assay kits.

The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for point-of-care inflammatory testing, rising integration of automated diagnostics platforms, expansion of preventive healthcare screening, growing adoption of high-throughput laboratory systems, increasing focus on personalized medicine diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity crp assays, rising use of automated immunoassay systems, growing demand for rapid inflammation diagnostics, expansion of crp testing in cardiovascular risk assessment, enhanced focus on laboratory workflow automation.

The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.

Major players in the C-Reactive Protein testing market are focusing on technological advancements such as high-sensitivity automated immunoassays for more accurate, rapid, and low-level CRP detection, supporting early cardiovascular risk assessment and real-time inflammation monitoring. High-sensitivity automated immunoassays use refined immunoturbidimetric or nephelometric techniques to detect CRP levels far below standard assays, enabling earlier intervention and improved prognostic evaluation. In January 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, launched the Atellica CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay for its Atellica CH Analyzer. The system uses two ready-to-use reagent packs and measures light scattering caused by CRP-induced particle aggregation, providing rapid, quantitative results compatible with serum or plasma samples for timely clinical decision-making.

In July 2024, Roche, a Switzerland-based diagnostics company, acquired LumiraDx's point-of-care platform for an undisclosed amount. Through this acquisition, Roche seeks to enhance its CRP testing capabilities by incorporating LumiraDx's rapid, quantitative CRP assay into its diagnostics portfolio and expanding access to point-of-care immunoassays. LumiraDx is a UK-based company that offers a multi-assay point-of-care platform, including a microfluidic immunoassay for quantitative C-Reactive Protein testing.

Major companies operating in the c-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

North America was the largest region in the c-reactive protein testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

C-Reactive Protein Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA); Chemiluminescence Immunoassay (CLIA); Immunoturbidimetric Assays
  • 2) By Application: Diabetes; Rheumatoid Arthritis; Cardiovascular Disease; Inflammatory Bowel Disease; Cancer; Other Applications
  • 3) By End Use: Clinics; Hospitals; Diagnostic Laboratories
  • Subsegments:
  • 1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA
  • 2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA; Automated CLIA Systems
  • 3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays; Latex Agglutination Immunoturbidimetric Assays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche AG; Danaher Corporation; Quest Diagnostics Incorporated; Siemens AG; Abbott Laboratories; Aidian Oy; Boditech Med Inc.; Horiba Ltd.; Laboratory Corporation; Merck KGAA; Randox Laboratories Limited; Getein Biotech Inc.; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Eurofins Scientific SE; Inova Diagnostics Inc.; Luminex Corporation; Sekisui Diagnostics LLC; Sysmex Corporation; Tosoh Corporation; Trinity Biotech Plc; WerfenLife Group LLC; ZEUS Scientific Inc.; BioMerieux SA; Biomerica Inc.; Gold Standard Diagnostics Corp.; Immunodiagnostic Systems Holdings PLC; Nova Biomedical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. C-Reactive Protein Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global C-Reactive Protein Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. C-Reactive Protein Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global C-Reactive Protein Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Sensitivity Crp Assays
    • 4.2.2 Rising Use Of Automated Immunoassay Systems
    • 4.2.3 Growing Demand For Rapid Inflammation Diagnostics
    • 4.2.4 Expansion Of Crp Testing In Cardiovascular Risk Assessment
    • 4.2.5 Enhanced Focus On Laboratory Workflow Automation

5. C-Reactive Protein Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Clinics
  • 5.4 Specialty Care Centers
  • 5.5 Research Laboratories

6. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global C-Reactive Protein Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global C-Reactive Protein Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global C-Reactive Protein Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global C-Reactive Protein Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. C-Reactive Protein Testing Market Segmentation

  • 9.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
  • 9.2. Global C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
  • 9.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinics, Hospitals, Diagnostic Laboratories
  • 9.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct ELISA, Indirect ELISA, Sandwich ELISA
  • 9.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Luminometer-Based CLIA, Automated CLIA Systems
  • 9.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

10. C-Reactive Protein Testing Market Regional And Country Analysis

  • 10.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific C-Reactive Protein Testing Market

  • 11.1. Asia-Pacific C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China C-Reactive Protein Testing Market

  • 12.1. China C-Reactive Protein Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India C-Reactive Protein Testing Market

  • 13.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan C-Reactive Protein Testing Market

  • 14.1. Japan C-Reactive Protein Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia C-Reactive Protein Testing Market

  • 15.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia C-Reactive Protein Testing Market

  • 16.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea C-Reactive Protein Testing Market

  • 17.1. South Korea C-Reactive Protein Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan C-Reactive Protein Testing Market

  • 18.1. Taiwan C-Reactive Protein Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia C-Reactive Protein Testing Market

  • 19.1. South East Asia C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe C-Reactive Protein Testing Market

  • 20.1. Western Europe C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK C-Reactive Protein Testing Market

  • 21.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany C-Reactive Protein Testing Market

  • 22.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France C-Reactive Protein Testing Market

  • 23.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy C-Reactive Protein Testing Market

  • 24.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain C-Reactive Protein Testing Market

  • 25.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe C-Reactive Protein Testing Market

  • 26.1. Eastern Europe C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia C-Reactive Protein Testing Market

  • 27.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America C-Reactive Protein Testing Market

  • 28.1. North America C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA C-Reactive Protein Testing Market

  • 29.1. USA C-Reactive Protein Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada C-Reactive Protein Testing Market

  • 30.1. Canada C-Reactive Protein Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America C-Reactive Protein Testing Market

  • 31.1. South America C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil C-Reactive Protein Testing Market

  • 32.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East C-Reactive Protein Testing Market

  • 33.1. Middle East C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa C-Reactive Protein Testing Market

  • 34.1. Africa C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. C-Reactive Protein Testing Market Regulatory and Investment Landscape

36. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

  • 36.1. C-Reactive Protein Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. C-Reactive Protein Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. C-Reactive Protein Testing Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

37. C-Reactive Protein Testing Market Other Major And Innovative Companies

  • Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation

38. Global C-Reactive Protein Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The C-Reactive Protein Testing Market

40. C-Reactive Protein Testing Market High Potential Countries, Segments and Strategies

  • 40.1 C-Reactive Protein Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 C-Reactive Protein Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 C-Reactive Protein Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer